Garth Tormoen is an Oncology physician. OpenAlex indexes 70 publications with 2,222 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
645 N Arlington Ave Ste 120
Reno, NV 895034441
Telephone
775-848-2583Provider last certified this registry record 12 Nov 2022.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20241 payment
- Siemens Medical Solutions USA, Inc.Program year20222 payments
- Novocure Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
49.1%Corticosteroid49.1%Dexamethasone100%Part D≥19 patientsCardiovascular
30.2%Antiarrhythmic30.2%Lidocaine Hcl Viscous100%Part D<11 patientsAnti-infectives
20.8%Penicillins with extended spectrum20.8%Amoxicillin-Clavulanate Potass100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation Therapy
The Journal of Immunology
2020 - Targeting MerTK Enhances Adaptive Immune Responses After Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics
2020 - Warfarin Promotes Adaptive Immune Control of Tumors following Stereotactic Ablative Radiotherapy
International Journal of Radiation Oncology*Biology*Physics
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”